WO2002005850A3 - Enhancement of the action of anti-infective agents - Google Patents
Enhancement of the action of anti-infective agents Download PDFInfo
- Publication number
- WO2002005850A3 WO2002005850A3 PCT/ZA2001/000098 ZA0100098W WO0205850A3 WO 2002005850 A3 WO2002005850 A3 WO 2002005850A3 ZA 0100098 W ZA0100098 W ZA 0100098W WO 0205850 A3 WO0205850 A3 WO 0205850A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- group
- agents
- action
- gas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2416512A CA2416512C (en) | 2000-07-19 | 2001-07-19 | Enhancement of the action of anti-infective agents |
AU2001283586A AU2001283586A1 (en) | 2000-07-19 | 2001-07-19 | Enhancement of the action of anti-infective agents |
US10/345,204 US8329685B1 (en) | 2000-07-19 | 2003-01-16 | Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
US13/709,596 US8937074B2 (en) | 2000-07-19 | 2012-12-10 | Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200003644 | 2000-07-19 | ||
ZA2000/3644 | 2000-07-19 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ZA2001/000099 Continuation-In-Part WO2002005851A2 (en) | 2000-07-19 | 2001-07-19 | Enhancement of the action of central and peripheral nervous system agents |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/345,204 Continuation-In-Part US8329685B1 (en) | 2000-07-19 | 2003-01-16 | Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002005850A2 WO2002005850A2 (en) | 2002-01-24 |
WO2002005850A3 true WO2002005850A3 (en) | 2003-01-09 |
Family
ID=25588833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ZA2001/000098 WO2002005850A2 (en) | 2000-07-19 | 2001-07-19 | Enhancement of the action of anti-infective agents |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN100531799C (en) |
AU (1) | AU2001283586A1 (en) |
CA (1) | CA2416512C (en) |
WO (1) | WO2002005850A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1560589B1 (en) * | 2002-06-20 | 2006-10-04 | Astion Dermatology A/S | Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
CA2596920C (en) * | 2005-01-28 | 2015-05-05 | North-West University | Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
CN101426369A (en) * | 2006-02-27 | 2009-05-06 | 西北大学 | Composition in the form of a microemulsion containing free fatty acids and/or free fatty acid derivatives |
US20100297249A1 (en) * | 2007-07-05 | 2010-11-25 | North-West University | Enhancement of the efficacy of therapeutic proteins |
CN102293745B (en) * | 2011-08-25 | 2013-03-13 | 西北农林科技大学 | Natamycin nano-emulsion antifungal medicament and preparation method thereof |
US10363324B2 (en) | 2013-11-04 | 2019-07-30 | The South African Nuclear Energy Corporation Limited | Pharmaceutical composition |
KR102364840B1 (en) * | 2014-11-05 | 2022-02-18 | 삼성전자주식회사 | Pharmaceutical composition for treating a disease associated with demyelination of neuron and method of using the same |
CN105169368B (en) * | 2015-09-16 | 2018-09-07 | 福建傲农生物科技集团股份有限公司 | A kind of pharmaceutical composition for preventing piglet yellow-white dysentery |
SE540411C2 (en) * | 2016-01-27 | 2018-09-11 | Ultupharma Ab | New method of treating bacterial infections |
GB201612093D0 (en) * | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
SG11201811345TA (en) | 2016-07-14 | 2019-01-30 | Achaogen Inc | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections |
CN109260152A (en) * | 2018-11-13 | 2019-01-25 | 禹州市中医院 | A kind of lomefloxacin hydrochloride auristilla |
CN109937819A (en) * | 2019-03-19 | 2019-06-28 | 湖南农业大学 | A method of the resistance to alkali ability of enhancing rice simultaneously improves iron content in rice |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025213A1 (en) * | 1992-06-08 | 1993-12-23 | Pitmy International N.V. | Nitrous oxide containing dermatological composition |
WO1997017978A1 (en) * | 1995-11-13 | 1997-05-22 | Pitmy International N.V. | Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
-
2001
- 2001-07-19 AU AU2001283586A patent/AU2001283586A1/en not_active Abandoned
- 2001-07-19 WO PCT/ZA2001/000098 patent/WO2002005850A2/en active Application Filing
- 2001-07-19 CN CNB018157432A patent/CN100531799C/en not_active Expired - Fee Related
- 2001-07-19 CA CA2416512A patent/CA2416512C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025213A1 (en) * | 1992-06-08 | 1993-12-23 | Pitmy International N.V. | Nitrous oxide containing dermatological composition |
WO1997017978A1 (en) * | 1995-11-13 | 1997-05-22 | Pitmy International N.V. | Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
Also Published As
Publication number | Publication date |
---|---|
CA2416512A1 (en) | 2002-01-24 |
AU2001283586A1 (en) | 2002-01-30 |
CN100531799C (en) | 2009-08-26 |
WO2002005850A2 (en) | 2002-01-24 |
CN1458847A (en) | 2003-11-26 |
CA2416512C (en) | 2010-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002005851A3 (en) | Enhancement of the action of central and peripheral nervous system agents | |
NZ608755A (en) | Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same | |
US11523999B2 (en) | Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof | |
WO2002005850A3 (en) | Enhancement of the action of anti-infective agents | |
Greenfield et al. | A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis | |
US11406602B2 (en) | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof | |
HK1118013A1 (en) | Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines | |
WO2002067864A3 (en) | Coenzyme q products exhibiting high dissolution qualities | |
US20110217275A1 (en) | Compositions comprising probiotic bacteria of the strain bacillus coagulans and omega-3 polyunsaturated fatty acids or derivatives thereof | |
US20120201912A1 (en) | Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract | |
HUP0303864A2 (en) | Pharmaceutical composition based on macrolides for topical application in ophthalmology and process for its preparation | |
KR940003551A (en) | New pharmaceutical compositions containing W-3 polyunsaturated esters and methods of using them for topical treatment of lesions | |
KR20060072098A (en) | Combinations of vasoprotective agents and formulations containing them | |
WO2013138411A1 (en) | Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract | |
JPH04293991A (en) | Antioxidant containing peridinin as effective constituent and manufacture of peridinin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/00366 Country of ref document: ZA Ref document number: 200300366 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2416512 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018157432 Country of ref document: CN |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |